This study investigates why two strains of the parasite Leishmania major (5-ASKH and Friedlin) cause dramatically different disease outcomes in mice lacking T and B lymphocytes (Rag2 knockout mice), despite causing similar self-healing lesions in normal mice. In lymphocyte-deficient mice, the 5-ASKH strain induced severe, ulcerative skin lesions, while the Friedlin strain caused only mild, nodular lesions, even with similar parasite loads. The severe pathology from 5-ASKH was linked to a massive accumulation of neutrophils. Further investigation revealed that the 5-ASKH strain uniquely triggers a potent pro-inflammatory response in macrophages, the primary host cells for the parasite. RNA sequencing of infected macrophages showed that the 5-ASKH strain specifically upregulates key inflammatory genes, including Toll-like receptor 1/2 (TLR1/2). The crucial role of this signaling pathway was confirmed in mice deficient in MyD88 (a key TLR signaling molecule), which showed significantly reduced inflammation when infected with the 5-ASKH strain. The research concludes that the severity of leishmaniasis in immunocompromised hosts can be dictated by the specific parasite strain's ability to activate distinct innate immune pathways in macrophages, leading to uncontrolled, damaging neutrophilic inflammation.
Strain-Dependent Immune Activation Dictates Leishmaniasis Severity in the Absence of Lymphocytes
Initial Observation: Different Strains, Different Diseases: In immunocompromised mice lacking T and B lymphocytes (Rag2 knockout mice), infection with the L. major 5-ASKH strain leads to severe, ulcerative skin lesions and tissue destruction. In contrast, the Friedlin (FV9) strain causes only mild, nodular lesions, despite both strains replicating to similar numbers in the host.
Key Pathological Driver: Neutrophil Accumulation: The severe inflammation caused by the 5-ASKH strain was directly correlated with a massive and sustained accumulation of neutrophils (a type of white blood cell) at the site of infection by week four. This was not observed in mice infected with the milder Friedlin strain.
The Cellular Trigger: Macrophage Activation: The study identified that macrophages (the primary host cells for the parasite) were activated differently by the two strains. Macrophages from mice infected with the 5-ASKH strain showed significantly higher levels of pro-inflammatory activation markers (CD69, CD38, and MHC-II), suggesting they were mounting a more aggressive, and ultimately damaging, innate immune response.
Molecular Analysis: Identifying the Genetic Switch: To understand the molecular basis for this difference, researchers performed RNA sequencing on bone marrow-derived macrophages (BMDMs) infected with each strain. The 5-ASKH strain was found to upregulate a much larger set of inflammatory genes compared to the Friedlin strain.
Key Finding: Upregulation of Toll-Like Receptors: Among the most significantly upregulated genes in 5-ASKH-infected macrophages were Toll-like receptor 1 (TLR1) and Toll-like receptor 2 (TLR2). TLRs are critical pattern-recognition receptors that sense pathogens and initiate innate immune responses.
Confirmation of Pathway: The Role of MyD88: To prove that the TLR signaling pathway was responsible for the severe pathology, the researchers used MyD88 knockout mice. MyD88 is an essential adapter protein for signaling by TLR1/2. When these mice were infected with the highly pathogenic 5-ASKH strain, they exhibited significantly less inflammation and fewer infiltrating neutrophils, confirming that the MyD88-dependent signaling pathway is a critical driver of the strain-specific pathology.
Importance and Conclusion: The study demonstrates that the innate immune system's response to Leishmania is highly dependent on the specific parasite strain. In the absence of a controlling adaptive immune response (from lymphocytes), certain strains can over-activate macrophages via the TLR pathway, leading to a destructive cascade of neutrophil accumulation and severe tissue damage. This provides insight into why leishmaniasis can be so severe in immunocompromised patients.